Different Genes Active in Cancer Patients of Different Races
High Mutation Frequency Does Not Predict Poor Outcome in Certain Patient Cohorts
UK Biotechs Present Novel Technologies at BioTrinity 2017
Biotechnology Rolls on Despite Brexit Uncertainty
Avoiding Costly Errors in Bioassay Development
Developers Have a Range of Options When Optimizing Bioassays for Biologics
Screening Innovations and 3D Cell Culture Assay Developments
Showcased at ELRIG
New Tech Aids Drug Discovery
For full access to this article login to GEN Select now.
Optimizing the Delivery of Peptide-Based Therapeutics
Despite Processing Advantages, Peptides Pose Serious Delivery Challenges
- Interest in nonnatural peptide drugs has waxed and waned over the past 30 years. The science has been fascinating, but delivery and pharmacokinetic issues remain. During the 1990s, Affymax popularized libraries of short peptides immobilized on inert substrates, but these peptides never led to novel therapeutic molecules or ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.